These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 18406155)

  • 1. SAR and QSAR study on 2-aminothiazole derivatives, modulators of transcriptional repression in Huntington's disease.
    Leone S; Mutti C; Kazantsev A; Sturlese M; Moro S; Cattaneo E; Rigamonti D; Contini A
    Bioorg Med Chem; 2008 May; 16(10):5695-703. PubMed ID: 18406155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of human tyrosine hydroxylase gene by neuron-restrictive silencer factor.
    Kim SM; Yang JW; Park MJ; Lee JK; Kim SU; Lee YS; Lee MA
    Biochem Biophys Res Commun; 2006 Jul; 346(2):426-35. PubMed ID: 16764822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genome-wide analysis of repressor element 1 silencing transcription factor/neuron-restrictive silencing factor (REST/NRSF) target genes.
    Bruce AW; Donaldson IJ; Wood IC; Yerbury SA; Sadowski MI; Chapman M; Göttgens B; Buckley NJ
    Proc Natl Acad Sci U S A; 2004 Jul; 101(28):10458-63. PubMed ID: 15240883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. REST4-mediated modulation of REST/NRSF-silencing function during BDNF gene promoter activation.
    Tabuchi A; Yamada T; Sasagawa S; Naruse Y; Mori N; Tsuda M
    Biochem Biophys Res Commun; 2002 Jan; 290(1):415-20. PubMed ID: 11779185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding of the repressor complex REST-mSIN3b by small molecules restores neuronal gene transcription in Huntington's disease models.
    Conforti P; Zuccato C; Gaudenzi G; Ieraci A; Camnasio S; Buckley NJ; Mutti C; Cotelli F; Contini A; Cattaneo E
    J Neurochem; 2013 Oct; 127(1):22-35. PubMed ID: 23800350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Widespread disruption of repressor element-1 silencing transcription factor/neuron-restrictive silencer factor occupancy at its target genes in Huntington's disease.
    Zuccato C; Belyaev N; Conforti P; Ooi L; Tartari M; Papadimou E; MacDonald M; Fossale E; Zeitlin S; Buckley N; Cattaneo E
    J Neurosci; 2007 Jun; 27(26):6972-83. PubMed ID: 17596446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasmids containing NRSE/RE1 sites enhance neurite outgrowth of retinal ganglion cells via sequestration of REST independent of NRSE dsRNA expression.
    Koch JC; Barski E; Lingor P; Bähr M; Michel U
    FEBS J; 2011 Sep; 278(18):3472-83. PubMed ID: 21790997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High throughput screening for inhibitors of REST in neural derivatives of human embryonic stem cells reveals a chemical compound that promotes expression of neuronal genes.
    Charbord J; Poydenot P; Bonnefond C; Feyeux M; Casagrande F; Brinon B; Francelle L; Aurégan G; Guillermier M; Cailleret M; Viegas P; Nicoleau C; Martinat C; Brouillet E; Cattaneo E; Peschanski M; Lechuga M; Perrier AL
    Stem Cells; 2013 Sep; 31(9):1816-28. PubMed ID: 23712629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of the repressor element-1 silencing transcription factor/neuron-restrictive silencer factor occupancy of non-neuronal genes in peripheral lymphocytes from patients with Huntington's disease.
    Marullo M; Valenza M; Mariotti C; Di Donato S; Cattaneo E; Zuccato C
    Brain Pathol; 2010 Jan; 20(1):96-105. PubMed ID: 19134002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo delivery of DN:REST improves transcriptional changes of REST-regulated genes in HD mice.
    Conforti P; Mas Monteys A; Zuccato C; Buckley NJ; Davidson B; Cattaneo E
    Gene Ther; 2013 Jun; 20(6):678-85. PubMed ID: 23151521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rescue of gene expression by modified REST decoy oligonucleotides in a cellular model of Huntington's disease.
    Soldati C; Bithell A; Conforti P; Cattaneo E; Buckley NJ
    J Neurochem; 2011 Feb; 116(3):415-25. PubMed ID: 21105876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Turning REST/NRSF dysfunction in Huntington's disease into a pharmaceutical target.
    Rigamonti D; Mutti C; Zuccato C; Cattaneo E; Contini A
    Curr Pharm Des; 2009; 15(34):3958-67. PubMed ID: 19751206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulatory role of neuron-restrictive silencing factor in the specific expression of cocaine- and amphetamine-regulated transcript gene.
    Li Y; Liu Q; Yang Y; Lv Y; Chen L; Bai C; Nan X; Wang Y; Pei X
    J Neurochem; 2008 Aug; 106(3):1314-24. PubMed ID: 18485095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validated quantitative structure-activity relationship analysis of a series of 2-aminothiazole based p56(Lck) inhibitors.
    Li J; Du J; Xi L; Liu H; Yao X; Liu M
    Anal Chim Acta; 2009 Jan; 631(1):29-39. PubMed ID: 19046675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evolution of the vertebrate gene regulatory network controlled by the transcriptional repressor REST.
    Johnson R; Samuel J; Ng CK; Jauch R; Stanton LW; Wood IC
    Mol Biol Evol; 2009 Jul; 26(7):1491-507. PubMed ID: 19318521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NRSF downregulation induces neuronal differentiation in mouse embryonic stem cells.
    Gupta SK; Gressens P; Mani S
    Differentiation; 2009 Jan; 77(1):19-28. PubMed ID: 19281761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The design and synthesis of 2-aminothiazole derivatives and their inhibitory activity on apoptosis].
    Jiang FC; Cheng CY
    Yao Xue Xue Bao; 2006 Aug; 41(8):727-34. PubMed ID: 17039777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human accelerated region 1 noncoding RNA is repressed by REST in Huntington's disease.
    Johnson R; Richter N; Jauch R; Gaughwin PM; Zuccato C; Cattaneo E; Stanton LW
    Physiol Genomics; 2010 May; 41(3):269-74. PubMed ID: 20179156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-based approach to pharmacophore identification, in silico screening, and three-dimensional quantitative structure-activity relationship studies for inhibitors of Trypanosoma cruzi dihydrofolate reductase function.
    Schormann N; Senkovich O; Walker K; Wright DL; Anderson AC; Rosowsky A; Ananthan S; Shinkre B; Velu S; Chattopadhyay D
    Proteins; 2008 Dec; 73(4):889-901. PubMed ID: 18536013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Remote control of activity-dependent BDNF gene promoter-I transcription mediated by REST/NRSF.
    Hara D; Fukuchi M; Miyashita T; Tabuchi A; Takasaki I; Naruse Y; Mori N; Kondo T; Tsuda M
    Biochem Biophys Res Commun; 2009 Jul; 384(4):506-11. PubMed ID: 19426709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.